TransCode Therapeutics Reports 2022 Results; Provides Business Update
BOSTON, March 31, 2023 -- TransCode Therapeutics, Inc. , the RNA oncology company committed to defeating cancer using RNA therapeutics, today reported financial results for 2022 and recent business... | March 31, 2023
United States Zdravka Medarova Michael Dudley Alan Freidman University Of Texas Md Anderson Cancer Center Exchange Commission
Source: marketscreener.com